ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among Tuberculosis Patients Who "Successfully" Completed Treatment in South Africa.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
backgroundTimeously completing tuberculosis (TB) treatment is a key to optimal health outcomes. Suboptimal treatment refill patterns, even among those categorized as "treatment success," may portend unfavorable outcomes.
methodsUsing patient-level medication refill data, latent-class mixed modeling was used to identify longitudinal trajectories of care engagement among TB patients achieving programmatic treatment success. Logistic regression was conducted to investigate participant-level characteristics associated with trajectory class membership.
resultsAmong 548 participants, we identified 3 trajectories: Class 1 (consistent engagement; 84.1%), Class 2 (suboptimal engagement after 2 months; 7.7%), and Class 3 (suboptimal engagement from initiation; 8.2%). At treatment completion, Classes 1-3 accumulated 9.7 (95% confidence interval [CI]: 7.4-11.8), 68.4 (60.4-76.9), and 55.5 (48.1-62.7) missed refill days, respectively. In gender-stratified models, men exhibited all 3 trajectories (83.1%, 7.4%, and 9.5%, respectively), and accumulated 10.6 (7.8-13.3), 61.0 (50.2-71.3), and 62.31 (53.14-71.72) missed refill days, respectively. Women exhibited only Classes 1 and 3 (89.5% and 10.5%, respectively) and accumulated 12.1 (7.8-16.5) and 46.9 (33.3-61.6) missed refill days, respectively. Among men, prior TB (Class 2: adjusted odds ratio [aOR] 7.44, 2.79-19.8; Class 3: aOR 2.78, 1.07-7.25) and human immunodeficiency virus-negative status (Class 3: aOR 2.72, 1.13-6.54) were associated with suboptimal trajectories. Among women, prior TB was associated with suboptimal engagement (aOR 5.22, 1.11-24.44).
conclusionsProgrammatic "treatment success" obscured heterogeneity in treatment refill patterns. Patient-centered counseling and gender-responsive interventions are needed to address treatment refill behaviors. Shorter regimens alone may not resolve suboptimal engagement, highlighting the need for flexible treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.